A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .
MODERNA (MRNA, Financial) secured a major legal win in its COVID-19 vaccine patent dispute with Pfizer (PFE, Financial) and ...
Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...
16h
DPA International on MSNModerna wins patent lawsuit against BioNTech/Pfizer in German courtA German court ruled on Wednesday that BioNTech and Pfizer violated a Covid-19 patent held by rival Moderna. US-based Moderna had asserted claims for information and damages for infringement of its ...
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...
The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...
Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...
CNET on MSN10h
How the 3 New COVID Vaccines Change the Way You PayNow that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.
If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per violation.
Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results